🇩🇪 Germany Country × Condition
prostate cancer Clinical Trials in Germany
Active clinical trials for prostate cancer with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2, Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇩🇪 Germany
Active Trials in Germany (4)
NCT05413850 Phase 1, Phase 2
Recruiting
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Enrollment
82 pts
Country
🇩🇪 Germany
Blue Earth Therapeutics Ltd
View Trial → NCT06122584 Phase 3
Recruiting
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer
Enrollment
434 pts
Country
🇩🇪 Germany
ABX advanced biochemical compounds ...
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇩🇪 Germany
UMC Utrecht
View Trial → NCT04083937
Recruiting
Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies
Enrollment
897 pts
Country
🇩🇪 Germany
University Hospital Heidelberg
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in Germany?
There are currently 4 active clinical trials for prostate cancer with sites in Germany, of which 4 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Germany?
To join a prostate cancer clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Germany?
Active prostate cancer trials in Germany span Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology